Analysis of changes in the ocular surface immune microenvironment due to video terminal stress

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300073398

Enrollment

Unknown

Registered

2023-07-10

Start date

2022-07-28

Completion date

Unknown

Last updated

2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VDT

Interventions

Experimental group:the use of visual display terminal

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Healthy subjects aged 18-40 years

Exclusion criteria

Exclusion criteria: 1. previous history of ocular trauma and ocular surgery (including refractive surgery) 2. history of ocular disease other than dry eye and refractive error 3. Wearing contact lens 1 week before the examination 4. comorbid autoimmune disease or use of immunosuppressive drugs within 1 month 5. concurrently enrolled in any other clinical trial 6. Subjects who, in the judgment of the investigator, may have a systemic disease that makes them unsuitable for participation in this study

Design outcomes

Primary

Measure	Time frame
tear film breakup time;Ocular Surface Disease Index;	—

Secondary

Measure	Time frame
metagenomic sequencing;RNA-sequencing;flow cytometry;Blinking Analysis;	—

Countries

China

Contacts

Public ContactChen Wei

The Eye Hospital of Wenzhou Medical University

chenwei@eye.ac.cn+86 137 5772 8118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026